Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

Joseph Tam; V. Kiran Vemuri; Jie Liu; Sándor Bátkai; Bani Mukhopadhyay; Grzegorz Godlewski; Douglas Osei-Hyiaman; Shinobu Ohnuma; Suresh V. Ambudkar; James Pickel; Alexandros Makriyannis; George Kunos

首页> 外文期刊>The journal of clinical investigation >Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

【24h】

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

机译：周围型CB1大麻素受体阻滞改善肥胖小鼠模型的心脏代谢风险

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Original citation: J Clin Invest. 2010;120(8):29532966. doi:10.1172/JCI42551.Citation for this corrigendum: J Clin Invest. 2010;120(10):3735. doi:10.1172/JCI42551C1.

机译：原始引用：J Clin Invest。 2010; 120（8）：29532966。 doi：10.1172 / JCI42551。该勘误的引文：J Clin Invest。 2010; 120（10）：3735。 doi：10.1172 / JCI42551C1。

著录项

来源
《The journal of clinical investigation 》 |2010年第10期| 共1页
作者
Joseph Tam; V. Kiran Vemuri; Jie Liu; Sándor Bátkai; Bani Mukhopadhyay; Grzegorz Godlewski; Douglas Osei-Hyiaman; Shinobu Ohnuma; Suresh V. Ambudkar; James Pickel; Alexandros Makriyannis; George Kunos;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类临床医学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity [J] . Joseph Tam, V. Kiran Vemuri, Jie Liu, The journal of clinical investigation . 2010 ,第8期

机译：周围型CB1大麻素受体阻滞改善肥胖小鼠模型的心脏代谢风险
2. Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity,smoking cessation and cardiometabolic risk factors [J] . Eli V Gelfand, Christopher P Cannon Expert opinion on investigational drugs . 2006 ,第3期

机译：利莫那班：大麻素CB1受体的选择性阻滞剂，用于治疗肥胖，戒烟和心脏代谢危险因素
3. Peripheral cannabinoid 1 receptor blockade mitigates adipose tissue inflammation via NLRP3 inflammasome in mouse models of obesity [J] . Han Ji H., Shin Hanho, Rho Jun G., Diabetes, obesity & metabolism . 2018 ,第9期

机译：外周大麻素1受体阻断减轻通过NLRP3肥胖的NLRP3炎性脂肪组织炎症
4. THE ROLE OF ANANDAMIDE AND RELATED FATTY ACID ETHANOLAMIDES AS ENDOGENOUS LIGANDS FOR THE CB1 AND CB2 CANNABINOID RECEPTORS [C] . Christian C. Felder, Amie Nielsen, Eileen M. Briley, International Washington Spring Symposium . 1996

机译：Anandamide和相关脂肪酸乙醇酰胺作为CB1和CB2大麻素受体的内源配体的作用
5. Cannabinoid CB1 receptors in the hippocampus of the APP/PS1 double transgenic murine model of Alzheimer's disease neuropathology. [D] . Kalifa, Sara. 2009

机译：APP / PS1双重转基因鼠科动物阿尔茨海默氏病神经病理学模型海马中的大麻素CB1受体。
6. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity [O] . Joseph Tam, V. Kiran Vemuri, Jie Liu, 2010

机译：周围型CB1大麻素受体阻滞剂改善肥胖小鼠模型的心脏代谢风险
7. Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity [O] . Tam, Joseph, Vemuri, V. Kiran, Liu, Jie, 2010

机译：周围型CB1大麻素受体阻滞剂改善肥胖小鼠模型的心脏代谢风险

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

摘要

著录项

相似文献

相关主题

期刊订阅